Thoracic Oncology Program »  Meet the Team »  Medical Oncologists »  Melisa L. Wong, M.D., M.A.S.
Melisa L. Wong, M.D., M.A.S.

Melisa L. Wong, M.D., M.A.S.

Assistant Clinical Professor
Division of Hematology/Oncology
Department of Medicine

Contact Information

Thoracic Surgery & Oncology Clinic
1600 Divisadero St., 4th Floor
San Francisco, CA 94143
(415) 885-3882 Appointments
(415) 353-7151 Clinic Fax
melisa.wong@ucsf.edu
Open Popup
  • Stanford University, B.A., Human Biology with Honors and Distinction, 2005
  • UCSF School of Medicine, M.D., 2011
  • UCSF Master's Degree Program in Clinical Research, M.A.S., 2017
  • UCSF, Internship in Internal Medicine, 2011-12
  • UCSF, Residency in Internal Medicine, 2012-14
  • UCSF, Fellowship in Medical Oncology, 2014-17 (2015 Quality Chief Fellow, 2016 Chief Fellow)
  • UCSF, Aging Research T32 Fellowship, 2015-17
  • American Board of Internal Medicine, Internal Medicine
  • Department of Medicine, Division of Hematology/Oncology
  • Thoracic Oncology Program
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Cancer outcomes research
  • Functional status
  • Geriatric oncology
  • Quality of life
  • Treatment toxicity

Melisa L. Wong, M.D., M.A.S. is a thoracic oncologist who treats patients with lung cancer and other thoracic malignancies. Dr. Wong has a particular interest in caring for older adults with cancer. Her goal is to provide personalized cancer care based on patients' values and goals.

Dr. Wong completed medical school and training in internal medicine and medical oncology at UCSF. She also completed advanced research training as an Aging Research T32 Fellow in the UCSF Division of Geriatrics and earned her Master's Degree in Clinical Research in the UCSF Department of Epidemiology and Biostatistics. Dr. Wong is a member of the American Society of Clinical Oncology, Cancer and Aging Research Group, Alliance for Clinical Trials in Oncology, International Society of Geriatric Oncology, International Association for the Study of Lung Cancer, and American Geriatrics Society.

  • Merit Award - Annual Meeting, Conquer Cancer Foundation of ASCO, 2017
  • SIOG Young Investigator Award, International Society of Geriatric Oncology (SIOG), 2017
  • Loan Repayment Program Award, NIH/NCI, 2017-2019
  • Merit Award - Quality Care Symposium, Conquer Cancer Foundation of ASCO, 2017
  • Vicky Merryman Women Who Conquer Cancer Young Investigator Award, Conquer Cancer Foundation of ASCO, 2017-2018
  • Merit Award - Annual Meeting, Conquer Cancer Foundation of ASCO, 2016
  • Merit Award - Quality Care Symposium, Conquer Cancer Foundation of ASCO, 2016
  • Butler-Williams Scholars Program, National Institute on Aging, 2016
  • Hematology/Oncology Division Clinical Fellow Award, UCSF Department of Medicine, 2016
  • Hematology/Oncology Chief Fellow, UCSF, 2016
  • Award for Excellence in Fellowship Research, UCSF Hematology/Oncology Research Retreat, 2016
  • Hematology/Oncology Quality Chief Fellow, UCSF, 2015
  • Cancer and Aging Research U13 Conference Young Investigator Travel Award, 2015
  • Department of Medicine Professionalism Award, UCSF, 2014
  • SOM Dean's Quarterly Research Fellowship, UCSF, 2011
  • Alpha Omega Alpha Honor Medical Society, UCSF, 2010
  • Bernard Osher Scholarship, UCSF, 2008-2011
  • SOM Dean's Summer Research Fellowship, UCSF, 2008
  • Joshua Lederberg Award for Academic Excellence in Human Biology, Stanford University, 2005
  • Chappell Lougee Scholarship, Stanford University, 2003
View all

Dr. Wong's research focuses on understanding and improving patient-centered outcomes in older adults with cancer. She is currently studying the impact of lung cancer treatment (such as chemotherapy, immunotherapy, and targeted therapy) on patients' functional status and quality of life. Dr. Wong also studies how symptoms change over time in older adults with cancer. 

Dr. Wong's forthcoming study, "Lung Cancer in Older Adults: Treatment Toxicity Through the Patient's Lens," will recruit UCSF lung cancer patients who are age 65 or older and starting a new chemotherapy, immunotherapy, or targeted therapy regimen. Dr. Wong and her research team will explore how lung cancer treatment impacts patients' functional status and quality of life.  

  • UCSF Clinical and Translational Science Institute Career Development Program (CTSI KL2), 2017-20
  • UCSF Claude D. Pepper Older Americans Independence Center Research Education Core Scholar Award, 2017-18
  • Conquer Cancer Foundation of ASCO/Vicky Merryman Women Who Conquer Cancer Young Investigator Award, 2017-18
Most recent publications from a total of 16
  1. Miaskowski C, Wong ML, Cooper BA, Mastick J, Paul SM, Possin K, Steinman M, Cataldo J, Dunn LB, Ritchie C. Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy. J Pain Symptom Manage. 2017 Sep; 54(3):263-272. View in PubMed
  2. Wong ML, Cooper BA, Paul SM, Levine JD, Conley YP, Wright F, Hammer M, Miaskowski C. Differences in Symptom Clusters Identified Using Ratings of Symptom Occurrence vs. Severity in Lung Cancer Patients Receiving Chemotherapy. J Pain Symptom Manage. 2017 Aug; 54(2):194-203. View in PubMed
  3. Wong ML, Paul SM, Cooper BA, Dunn LB, Hammer MJ, Conley YP, Wright F, Levine JD, Walter LC, Cartwright F, Miaskowski C. Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy. Support Care Cancer. 2017 Jun; 25(6):1931-1939. View in PubMed
  4. Miaskowski C, Mastick J, Paul SM, Topp K, Smoot B, Abrams G, Chen LM, Kober KM, Conley YP, Chesney M, Bolla K, Mausisa G, Mazor M, Wong M, Schumacher M, Levine JD. Chemotherapy-Induced Neuropathy in Cancer Survivors. J Pain Symptom Manage. 2017 Aug; 54(2):204-218.e2. View in PubMed
  5. Wong ML, McMurry TL, Stukenborg GJ, Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg CC, Winchester DP, McKellar DP, Walter LC, Kozower BD. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Lung Cancer. 2016 Dec; 102:108-117. View in PubMed
  6. Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ, Redman MW, Manola JB, Schilsky RL, Cohen HJ, Bradley JD, Adjei AA, Gandara D, Ramalingam SS, Vokes EE. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012. J Clin Oncol. 2016 Sep 19. View in PubMed
  7. Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, Karuturi MS, Kimmick GG, Lichtman SM, Magnuson A, Whitehead MI, Wong ML, Ahles TA. Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol. 2016 Jul; 7(4):270-80. View in PubMed
  8. Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM, Inouye SK, Dale W, Loh KP, Whitehead MI, Magnuson A, Hurria A, Janelsins MC, Mohile S. Understanding cognition in older patients with cancer. J Geriatr Oncol. 2016 Jul; 7(4):258-69. View in PubMed
  9. Tang VL, Shi Y, Fung K, Tan J, Espaldon R, Sudore R, Wong ML, Walter LC. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy. JAMA Intern Med. 2016 May 01; 176(5):654-61. View in PubMed
  10. Wong ML, Clarke CA, Yang J, Hwang J, Hiatt RA, Wang S. Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status. J Thorac Oncol. 2013 Mar; 8(3):287-94. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Melisa L. Wong, M.D., M.A.S.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X